Emily Davis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Emily Davis has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Jeroen Eyckmans
Department of Biomedical Engineering and the Biological Design Center, Boston University, Boston, MA 02215, USA
3 shared publications - Wilson W. Wong
Department of Biomedical Engineering, Boston University, Boston, MA, USA
3 shared publications - Anish Vasan
Department of Biomedical Engineering and the Biological Design Center, Boston University, Boston, MA, 02215, United States
2 shared publications - Christopher S. Chen
Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215, USA
2 shared publications Elena Westphal
Department of Biomedical Engineering and the Biological Design Center, Boston University, Boston, MA, 02215, United States
2 shared publications- Emma Lejeune
Department of Mechanical Engineering, Boston University, Boston, USA
2 shared publications
Latest Publications
- Open Access
A high-throughput, 3D microtissue platform for multiparametric analysis of tissue remodeling
Extracellular matrix (ECM) remodeling and force generation are fundamental drivers of tissue morphogenesis and repair, yet scalable methods to quantitatively interrogate these dynamic mechanical processes remain limited. Here, we present a high-throughput screening platform that integrates engineered three-dimensional (3D) microtissues within a standardized 96-well format. We introduce a robust mold-casting fabrication process and a layer-by-layer surface modification strategy, that ensures long-term tissue stability and prevents detachment (95% tissue formation success; stable in culture for more than 10 days). This system enables simultaneous, longitudinal quantification of tissue closure, tissue contractility, and tissue compaction from a phase-contrast imaging modality. The computational data analysis tools that accompany this framework ensure reproducibility through deterministic computation and accelerate data extraction 80-fold relative to manual annotation. Using pharmacological compounds, we show that tissue closure dynamics, force generation, and compaction represent independent variables of ECM-driven tissue remodeling, challenging assumptions embedded in commonly used contraction-based assays. Furthermore, benchmarking against reported clinical drug responses demonstrates that the 3D platform better aligns with clinical outcomes (Kendall τ-b = 0.72, p= 0.045 , n =8/10) than a conventional two-dimensional scratch wound assay (Kendall τ-b = 0.52, p= 0.25 , n =4/10). Together, this work establishes a scalable assay for functional screening and quantitative assessment of tissue remodeling dynamics in three-dimensional systems.
Open AccessA high-throughput, 3D microtissue platform for multiparametric analysis of tissue remodeling
Extracellular matrix (ECM) remodeling and force generation are fundamental drivers of tissue morphogenesis and repair, yet scalable methods to quantitatively interrogate these dynamic mechanical processes remain limited. Here, we present a high-throughput screening platform that integrates engineered three-dimensional (3D) microtissues within a standardized 96-well format. We introduce a robust mold-casting fabrication process and a layer-by-layer surface modification strategy, that ensures long-term tissue stability and prevents detachment (95% tissue formation success; stable in culture for more than 10 days). This system enables simultaneous, longitudinal quantification of tissue closure, tissue contractility, and tissue compaction from a phase-contrast imaging modality. The computational data analysis tools that accompany this framework ensure reproducibility through deterministic computation and accelerate data extraction 80-fold relative to manual annotation. Using pharmacological compounds, we show that tissue closure dynamics, force generation, and compaction represent independent variables of ECM-driven tissue remodeling, challenging assumptions embedded in commonly used contraction-based assays. Furthermore, benchmarking against reported clinical drug responses demonstrates that the 3D platform better aligns with clinical outcomes (Kendall τ-b = 0.72, p= 0.045 , n =8/10) than a conventional two-dimensional scratch wound assay (Kendall τ-b = 0.52, p= 0.25 , n =4/10). Together, this work establishes a scalable assay for functional screening and quantitative assessment of tissue remodeling dynamics in three-dimensional systems.
- 24 June 2026
- Published by EMBL-EBI
A high-throughput, 3D microtissue platform for multiparametric analysis of tissue remodeling
- 24 June 2026
- Published by EMBL-EBI
A high-throughput, 3D microtissue platform for multiparametric analysis of tissue remodeling
- Open Access
- 30 March 2026
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 26 (14) , 4160-4175
A 3D microfluidic model of exchange between perfused blood and lymphatic microvascular networks
Blood and lymphatic microvascular networks function as integrated systems within tissues, exchanging fluid, molecules, and cells to regulate homeostasis and immune responses, yet current in vitro models primarily study these systems in isolation. Existing blood-lymphatic culture models either lack in vivo-like network architecture or cannot achieve independent perfusion of the two vascular compartments, preventing their use in modeling cross-network transport interactions. Here, we present a novel microfluidic platform that supports the formation of independently perfusable, self-assembled blood and lymphatic microvascular networks with physiologically relevant architecture, surface area, and spatial organization. This model was created using a tape-based laminated microfluidic device and sequential gel casting approach to spatially pattern blood and lymphatic endothelial cells within a continuous matrix environment, allowing the two networks to co-develop and become independently perfusable without compromising cross-network transport capacity. High-resolution imaging confirmed that both networks matured progressively over 5 days, maintaining distinct identities, morphology, and barrier integrity under optimized growth factor conditions. Functional validation demonstrated size-selective transport between networks and physiologically relevant T-cell migration from blood to lymphatic vessels, with enhanced trafficking under inflammatory (TNF-α), chemoattractant (SDF-1α), and activation conditions. These studies establish a new experimental platform for the investigation of molecular and cellular transport and signaling across the blood-lymphatic interface under diverse physiological and pathological conditions.
- 30 March 2026
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 26 (14) , 4160-4175
Open AccessA 3D microfluidic model of exchange between perfused blood and lymphatic microvascular networks
Blood and lymphatic microvascular networks function as integrated systems within tissues, exchanging fluid, molecules, and cells to regulate homeostasis and immune responses, yet current in vitro models primarily study these systems in isolation. Existing blood-lymphatic culture models either lack in vivo-like network architecture or cannot achieve independent perfusion of the two vascular compartments, preventing their use in modeling cross-network transport interactions. Here, we present a novel microfluidic platform that supports the formation of independently perfusable, self-assembled blood and lymphatic microvascular networks with physiologically relevant architecture, surface area, and spatial organization. This model was created using a tape-based laminated microfluidic device and sequential gel casting approach to spatially pattern blood and lymphatic endothelial cells within a continuous matrix environment, allowing the two networks to co-develop and become independently perfusable without compromising cross-network transport capacity. High-resolution imaging confirmed that both networks matured progressively over 5 days, maintaining distinct identities, morphology, and barrier integrity under optimized growth factor conditions. Functional validation demonstrated size-selective transport between networks and physiologically relevant T-cell migration from blood to lymphatic vessels, with enhanced trafficking under inflammatory (TNF-α), chemoattractant (SDF-1α), and activation conditions. These studies establish a new experimental platform for the investigation of molecular and cellular transport and signaling across the blood-lymphatic interface under diverse physiological and pathological conditions.